Patent · US Active

Substituted alpha-L-bicyclic nucleosides

US8501805B2 · kind B2 · utility

179Cited by
129References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2009
Grant dateAug 6, 2013
Priority date
Expiry dateMar 20, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure describes substituted α-L-bicyclic nucleoside analogs, oligomeric compounds prepared therefrom and methods of using the oligomeric compounds. More particularly, substituted α-L-bicyclic nucleoside analogs are provided, having one or more chiral substituents, that are useful for enhancing properties of oligomeric compounds including binding affinity. In some embodiments, the oligomeric compounds provided herein hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.